Stephen P. Ethier, Ph.D.
Director, Center for Genomic Medicine
Countess Alicia Spaulding-Paolozzi
Endowed Chair in Breast Cancer Research
Hollings Cancer Center
The Center for Genomic Medicine at the Medical University of South Carolina was launched in 2013 with the goal of bringing cutting edge technology and expertise in genomics and genetics to MUSC. During the first two years of its existence, the Center sponsored a symposium in which national leaders in genomic medicine spent two days on campus to discuss their work and provide advice on how best to move the Center forward. Also during that time, the Center sponsored a number of pilot projects, and established the Bioinformatics Shared Resource led by Dr. Gary Hardiman. We also enhanced the capacity of the Genomic Sequencing Core lab, which is jointly operated by the Center for Genomic Medicine and the Hollings Cancer Center, by acquiring a state-of-the-art HighSeq 2500 Sequencer.
In July of 2015, the Center for Genomic Medicine took another step forward and is now poised to expand in scope. Over the coming year, with the guidance of our Internal Advisory Committee, we will establish a membership for the Center, we will plan the first ever CGM retreat, we will establish the CGM seminar series, and we will move forward with the next round of pilot project funding. We also hope to significantly expand the scope of patient sequencing, both for pediatric patients and also for cancer patients in collaboration with our colleagues in the Hollings Cancer Center. The goal of the CGM is to be the nexus for all translational research and clinical activities related to genetics and genomics at MUSC. In addition to sponsoring pilot grants, retreats, and seminars, it is my intention to leverage all of the modern tools of social media to keep the members of the Center connected with each other and informed about all aspects of activity of the Center and its members. I hope that by using these 21st Century tools, we can make rapid progress in the implementation of cutting edge technology for our research and most importantly for our patients. I’m looking forward to an exciting year of genomic research and medicine here at MUSC.